The multidimensional role of SLC16A4 in hepatocellular carcinoma in silico analysis: prognostic significance, metabolic pathways, and immune microenvironment regulation
Abstract Background: This study aims to analyze the expression patterns, clinical relevance, and biological functions of SLC16A4 across multiple cancer types, with a focus on liver hepatocellular carcinoma (LIHC) in silico analysis. Methods: We conducted a pan-cancer analysis using data from TCGA and GTEx databases to evaluate SLC16A4 expression in various cancer types. The LIHC cohort was stratified based on SLC16A4 expression levels for further clinicopathological and survival analysis. Functional enrichment, immune infiltration, and RNA modification correlations were explored using
This article is available to registered members
Create a free account to access our full library of peer-reviewed research on medical cannabis.
Join — it's freeAlready a member? Log in
